Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Hold on NuVasive, Raises Price Target to $51

Author: Benzinga Newsdesk | July 19, 2023 09:51am
Truist Securities analyst Richard Newitter maintains NuVasive (NASDAQ:NUVA) with a Hold and raises the price target from $48 to $51.

Posted In: NUVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist